XML 30 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands
6 Months Ended
Apr. 30, 2011
Apr. 30, 2010
Cash flow provided by (used) in operating activities:    
Net loss $ (17,356) $ (81,155)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 10,337 9,025
Stock-based compensation 7,970 7,350
Excess tax benefits from stock-based compensation   (2,606)
Impairments of investments in unconsolidated entities 39,600  
Income from unconsolidated entities and non-performing loan portfolio (17,728) (1,646)
Distributions of earnings from unconsolidated entities 6,789  
Deferred tax benefit (6,515) (10,963)
Deferred tax valuation allowances 6,515 10,963
Inventory impairments 18,048 75,712
Change in fair value of mortgage loans receivable and derivative instruments 818 (266)
Expenses related to early retirement of debt   34
Changes in operating assets and liabilities    
Increase in inventory (154,440) (192,804)
Origination of mortgage loans (301,778) (241,631)
Sale of mortgage loans 365,328 238,071
Decrease in restricted cash 28,781  
Decrease in receivables, prepaid expenses and other assets 7,172 3,086
Increase (decrease) in customer deposits 17,554 (6,407)
Decrease in accounts payable and accrued expenses (36,799) (305)
Decrease (increase) in income tax refund recoverable 141,590 (38,740)
(Decrease) increase in income taxes payable (18,241) 8,389
Net cash provided by (used in) operating activities 97,645 (223,893)
Cash flow used in investing activities:    
Purchase of property and equipment - net (5,112) (748)
Purchase of marketable securities (329,105) (85,450)
Sale and redemption of marketable securities 227,080  
Investment in and advances to unconsolidated entities and non-performing loan portfolio (42,141) (25,931)
Return of investments in unconsolidated entities 15,751 4,446
Net cash used in investing activities (133,527) (107,683)
Cash flow used in financing activities:    
Proceeds from loans payable 438,713 346,472
Principal payments of loans payable (498,960) (419,121)
Redemption of senior subordinated notes   (47,872)
Proceeds from stock-based benefit plans 4,676 4,124
Excess tax benefits from stock-based compensation   2,606
Receipts related to noncontrolling interest 2,678  
Purchase of treasury stock (389) (382)
Net cash used in financing activities (53,282) (114,173)
Net decrease in cash and cash equivalents (89,164) (445,749)
Cash and cash equivalents, beginning of period 1,039,060 1,807,718
Cash and cash equivalents, end of period $ 949,896 $ 1,361,939